Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

A roundup of news from Japan (Fujifilm), the UK (BI, Hikma, Perrigo) and the US (Nabriva Therapeutics, Lupin, Unichem, GSK, and La Jolla Pharmaceuticals). Japan Fujifilm Announces Approval of Adalimumab in JapanFujifilm Kyowa Kirin Biologics, a...

The World Health Organization (WHO) has released a detailed plan that seeks $31.3 billion in funding to support the Access to COVID-19 Tools (ACT) Accelerator, a global collaboration launched by the WHO and others to accelerate the development,...

Advanced Accelerator Applications (AAA), a Novartis company, has executed a sales and purchase agreement for a 50,000-square-foot piece of land in Indianapolis, Indiana to build a radioligand therapy manufacturing plant. The facility will expand...

The US Food and Drug Administration has issued final guidance that provides recommendations to pharmaceutical manufacturers on actions to take when an employee who has been directly involved in manufacturing drugs has a confirmed infection of...

Bayer has agreed to pay between $10.1 billion and $10.9 billion to resolve current and future product-liability litigation in the US over its glyphosate-based herbicide, Roundup, which the company acquired in its $63-billion acquisition of the...